GRADIAN HEALTH INDIA PRIVATE LIMITED
GRADIAN HEALTH INDIA PRIVATE LIMITED is a RAJASTHAN based PRIVATE LIMITED company, Registered at dated 12-FEB-2024 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of GRADIAN HEALTH INDIA PRIVATE LIMITED is U20299RJ2024PTC092636 and registration number is 092636.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC JAIPUR India. Authorized share capital of GRADIAN HEALTH INDIA PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
GRADIAN HEALTH INDIA PRIVATE LIMITED has 2 directors NEETU KULSHRESHTHA, NISHITHA KULSHRESHTHA,
The registered Email address of GRADIAN HEALTH INDIA PRIVATE LIMITED is Nishitha.kul@gmail.com and its registered address is FLAT NO.P -2, PANT HOUSE PLOT NO. 150 SHANTI NAGAR DURGAPURA JAIPUR JAIPUR RJ 302018 IN RAJASTHAN RAJASTHAN india 302018.
The current status of GRADIAN HEALTH INDIA PRIVATE LIMITED shows as NOT AVAILABLE FOR EFILING
COMPANY BASIC DETAILS
GRADIAN HEALTH INDIA PRIVATE LIMITED
ROC JAIPUR
NOT AVAILABLE FOR EFILING
U20299RJ2024PTC092636
12-FEB-2024
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
CONTACT DETAILS
302018
INDIA
FLAT NO.P -2, PANT HOUSE PLOT NO. 150 SHANTI NAGAR DURGAPURA JAIPUR JAIPUR RJ 302018 IN
Nishitha.kul@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
10505124 | NEETU KULSHRESHTHA | Director | 12/02/2024 |
10505125 | NISHITHA KULSHRESHTHA | Director | 12/02/2024 |
Details Updated by Companies
Quick Links
- All Registered company of RAJASTHAN
- Company Registered in RAJASTHAN
- All Registered company of JAIPUR in RAJASTHAN
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.